Epigenetic effects of high-fat diet on intestinal tumorigenesis in C57BL/6J-Apc^Min/+ mice

Abstract

Aim: Obesity and obesogenic diets might partly accelerate cancer development through epigenetic mechanisms. To determine these early effects, we investigated the impact of three days of a high-fat diet on epigenomic and transcriptomic changes in Apc^Min/+ murine intestinal epithelia.

Method: ChIP-Seq and RNA-Seq were performed on small intestinal epithelia of WT and Apc^Min/+ male mice fed high-fat diet (HFD) or low-fat diet (LFD) for three days to identify genomic regions associated with differential H3K27ac levels as a marker of variant enhancer loci (VELs) as well as differentially expressed genes (DEGs).

Results: Regarding epigenetic and transcriptomic changes, diet type (LFD vs. HFD) showed a significant impact, and genotype (WT vs. Apc^Min/+) showed a small impact. Compared to LFD, HFD resulted in 1306 gained VELs, 230 lost VELs, 133 upregulated genes, and 127 downregulated genes in WT mice, with 1056 gained VELs, 371 lost VELs, 222 upregulated genes, and 182 downregulated genes in Apc^Min/+ mice. Compared to the WT genotype, theApc^Min/+ genotype resulted in zero changed VELs for either diet type group, 21 DEGs for LFD, and 48 DEGs for HFD. Most gained VELs, and upregulated genes were associated with lipid metabolic processes. Gained VELs were also associated with Wnt signaling. Downregulated genes were associated with antigen presentation and processing.

Conclusion: Three days of HFD-induced epigenomic and transcriptomic changes involving metabolic and immunologic pathways that may promote tumor growth in the genetically predisposed murine intestine without affecting key cancer signaling pathways.

Keywords

Obesogenic diet / epigenetic changes / lipid metabolic processes / Apc ^Min/+

References

[1] Lauby-SecretanB,LoomisD,BianchiniF.Body fatness and cancer - viewpoint of the IARC working group.N Engl J Med2016;375:794-8 PMCID:PMC6754861

[2] DoernerSK,LeungES.High-fat diet-induced complement activation mediates intestinal inflammation and neoplasia, independent of obesity.Mol Cancer Res2016;14:953-65 PMCID:PMC5330314

[3] GoncalvesMD,TutnauerJ.High-fructose corn syrup enhances intestinal tumor growth in mice.Science2019;363:1345-9 PMCID:PMC6487857

[4] BergerNA.Targeting Epigenetics to prevent obesity promoted cancers.Cancer Prev Res2018;11:125-8

[5] LiR,ChrysovergisK.Obesity, rather than diet, drives epigenomic alterations in colonic epithelium resembling cancer progression.Cell Metab2014;19:702-11 PMCID:PMC4050048

[6] LiR,MavD.Transcriptome and DNA methylome analysis in a mouse model of diet-induced obesity predicts increased risk of colorectal cancer.Cell Rep2018;22:624-37 PMCID:PMC5793878

[7] Akhtar-ZaidiB,CorradinO.Epigenomic enhancer profiling defines a signature of colon cancer.Science2012;336:736-9 PMCID:PMC3711120

[8] CohenAJ,CorradinO.Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome.Nat Commun2017;8:14400 PMCID:PMC5309719

[9] SurwitR,RodinJ.Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and mice.Metabolism1995;44:645-51

[10] MortonAR,FaberZJ.Functional enhancers shape extrachromosomal oncogene amplifications.Cell2019;179:1330-1341.e13 PMCID:PMC7241652

[11] SchmidtD,SpyrouC,HadfieldJ.ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions.Methods2009;48:240-8 PMCID:PMC4052679

[12] LangmeadB,PopM.Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.Genome Biol2009;10:R25 PMCID:PMC2690996

[13] LiH,WysokerA.The sequence alignment/map format and SAMtools.Bioinformatics2009;25:2078-9 PMCID:PMC2723002

[14] ZhangY,MeyerCA.Model-based analysis of ChIP-Seq (MACS).Genome Biol2008;9:R137

[15] AmemiyaHM,BoyleAP.The ENCODE blacklist: identification of problematic regions of the genome.Sci Rep2019;9:9354 PMCID:PMC6597582

[16] Consortium EPAn integrated encyclopedia of DNA elements in the human genome.Nature2012;489:57-74

[17] RamírezF,DiehlS,MankeT.deepTools: a flexible platform for exploring deep-sequencing data.Nucleic Acids Res2014;42:W187-91 PMCID:PMC4086134

[18] ThorvaldsdóttirH,MesirovJP.Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration.Brief Bioinform2013;14:178-92 PMCID:PMC3603213

[19] QuinlanAR.BEDTools: a flexible suite of utilities for comparing genomic features.Bioinformatics2010;26:841-2 PMCID:PMC2832824

[20] LoveMI,AndersS.Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.Genome Biol2014;15:550 PMCID:PMC4302049

[21] DobinA,SchlesingerF.STAR: ultrafast universal RNA-seq aligner.Bioinformatics2013;29:15-21 PMCID:PMC3530905

[22] TrapnellC,SauvageauM,RinnJL.Differential analysis of gene regulation at transcript resolution with RNA-seq.Nat Biotechnol2013;31:46-53 PMCID:PMC3869392

[23] McLeanCY,HillerM.GREAT improves functional interpretation of cis-regulatory regions.Nat Biotechnol2010;28:495-501 PMCID:PMC4840234

[24] SzklarczykD,LyonD.STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.Nucleic Acids Res2019;47:D607-13 PMCID:PMC6323986

[25] HeinzS,SpannN.Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities.Mol Cell2010;38:576-89 PMCID:PMC2898526

[26] SethiJK.Wnt signalling and the control of cellular metabolism.Biochem J2010;427:1-17 PMCID:PMC4301310

[27] KanehisaM.KEGG: kyoto encyclopedia of genes and genomes.Nucleic Acids Res2000;28:27-30 PMCID:PMC102409

[28] TraversoN,NittiM.Role of glutathione in cancer progression and chemoresistance.Oxid Med Cell Longev2013;2013:972913 PMCID:PMC3673338

[29] KennedyL,HarperME.Role of glutathione in cancer: from mechanisms to therapies.Biomolecules2020;10:1429 PMCID:PMC7600400

[30] BeyazS,MouH.Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis.Cell Stem Cell2021;28:1922-1935.e5 PMCID:PMC8650761

[31] ChengC,ChengX.Lipid metabolism reprogramming and its potential targets in cancer.Cancer Commun2018;38:27 PMCID:PMC5993136

[32] LiH,HeML.Lipid metabolism alteration contributes to and maintains the properties of cancer stem cells.Theranostics2020;10:7053-69 PMCID:PMC7330842

[33] YiM,ChenS.Emerging role of lipid metabolism alterations in Cancer stem cells.J Exp Clin Cancer Res2018;37:118

[34] KoundourosN.Reprogramming of fatty acid metabolism in cancer.Br J Cancer2020;122:4-22 PMCID:PMC6964678

[35] MenendezJA.Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.Nat Rev Cancer2007;7:763-77

[36] LuoJ,LuY.Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.Cancer Lett2017;384:39-49 PMCID:PMC5110372

[37] LaiKKY,ChiF.Stearoyl-CoA desaturase promotes liver fibrosis and tumor development in mice via a wnt positive-signaling loop by stabilization of low-density lipoprotein-receptor-related proteins 5 and 6.Gastroenterology2017;152:1477-91 PMCID:PMC5406249

[38] NotoA,PisanuME.Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ.Oncogene2017;36:4573-84

[39] Vara-CiruelosD,HardieDG.The strange case of AMPK and cancer: Dr Jekyll or Mr Hyde?.Open Biol2019;9:190099 PMCID:PMC6685927

[40] BergerNA.Obesity and cancer pathogenesis.Ann N Y Acad Sci2014;1311:57-76 PMCID:PMC4500037

[41] BergerNA.Young adult cancer: influence of the obesity pandemic.Obesity2018;26:641-50 PMCID:PMC5868416